Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2017-08-09

FDA Approved: ISIBLOOM — Supplemental Application (Xiromed, LLC.)

View source ↗

Summary

FDA approved a supplemental application for ISIBLOOM, a combination oral contraceptive containing desogestrel and ethinyl estradiol, manufactured by Xiromed, LL…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ISIBLOOM (DESOGESTREL AND ETHINYL ESTRADIOL)

Snippet

SUPPL AP for ISIBLOOM (DESOGESTREL AND ETHINYL ESTRADIOL)